CDMO Kindeva Drug Delivery has announced that it will invest in a second MDI manufacturing line capable of filling lower global warming potential (GWP) propellants such as HFA 152a and HFO 1234ze in response to increasing demand. The company announced plans to install its first lower-GWP propellant filling line in November 2021. The new line is expected to be … [Read more...] about Kindeva announces second lower-GWP MDI manufacturing line
Products and Services
AstraZeneca partners with Honeywell on development of HFO-1234ze MDIs
AstraZeneca has announced a partnership with Honeywell for development of lower global warming potential MDIs using HFO-1234ze as a propellant. The company said that Breztri budesonide/ glycopyrronium/ formoterol fumarate is the first product it plans to convert to HFO-1234ze and that a Phase 1 trial of an HFO 1234ze formulation of budesonide/ glycopyrronium/ … [Read more...] about AstraZeneca partners with Honeywell on development of HFO-1234ze MDIs
Aptar Pharma breaks ground on new manufacturing facility in Mumbai
OINDP device manufacturer Aptar Pharma recently broke ground on new manufacturing facility on a 3.5 acre site in Mumbai, India, with the groundbreaking taking place on the tenth anniversary of the existing Aptar facility in Mumbai, the company said. Construction on the new facility is expected to be complete by the first quarter of 2023. The existing facility, … [Read more...] about Aptar Pharma breaks ground on new manufacturing facility in Mumbai
Aptar Pharma launches HeroTracker Sense MDI sensor
Aptar Pharma announced that it has launched a metered dose inhaler add-on sensor called HeroTracker Sense. According to Aptar, the device has been CE marked and is "pending FDA approval." HeroTracker inhaler sensors were originally developed by Cohero Health, which was acquired by Aptar in 2020. The company says that HeroTracker Sense, which snaps onto the MDI … [Read more...] about Aptar Pharma launches HeroTracker Sense MDI sensor
RxPack to distribute Biocorp’s Inspair inhaler sensor in certain territories
Biocorp and RxPack have announced a new distribution agreement giving RxPack the exclusive rights to commercialize Biocorp's Inspair inhaler sensor in Eastern Europe, Southeast Asia, South America, and the Middle East. Lindal had obtained the rights to market Inspair in those territories in 2018, and RxPack is a joint venture of Lindal and Coster which was formed in … [Read more...] about RxPack to distribute Biocorp’s Inspair inhaler sensor in certain territories
RxPack names Alberto Colombo as Head of R&D and Customer Technical Support
RxPack, a new device company formed from a joint venture between Lindal and Coster in 2021, has announced the appointment of inhaler development specialist Alberto Colombo as Head of R&D and Customer Technical Support. Colombo was most recently a device development specialist at Chiesi, where he managed MDI projects,and previously spent approximately 10 years … [Read more...] about RxPack names Alberto Colombo as Head of R&D and Customer Technical Support
ISAB announces positive results from PreciseInhale clinical trial
According to Inhalation Sciences (ISAB), topline data from a clinical trial of ISAB’s PreciseInhale aerosol generating system successfully demonstrated that the system is capable of targeting a dose to a specific lung region and that the dosing from PreciseInhale is more precise than doses delivered from a standard inhaler. The trial, which enrolled 12 healthy … [Read more...] about ISAB announces positive results from PreciseInhale clinical trial
H&T Presspart to market Biocorp’s Inspair MDI sensor
Device maker H&T Presspart has acquired the rights to market Biocorp’s Inspair inhaler sensor, the two companies have announced. The Inspair sensor, which fits onto standard metered dose inhalers, records inhaler usage data; provides audio and visual feedback on the patient's inhalation technique; and can be reused for up to two years. H&T Presspart will … [Read more...] about H&T Presspart to market Biocorp’s Inspair MDI sensor
Aerogen to supply nebulizers for delivery of CanSinoBio’s Convidecia inhaled COVID-19 vaccine
Nebulizer maker Aerogen and CanSino Biologics have signed a development and commercial supply deal for the use of Aerogen's vibrating mesh nebulizer technology for delivery of CanSinoBIO’s Convidecia inhaled vaccine against COVID-19. Terms of the deal were not disclosed. Earlier this year, CanSinoBio announced positive results from a Phase 1 trial of the Ad5-nCoV … [Read more...] about Aerogen to supply nebulizers for delivery of CanSinoBio’s Convidecia inhaled COVID-19 vaccine
Nanopharm announces expansion
OINDP contract research and development company Nanopharm, a subsidiary of Aptar Pharma, has announced plans to move to a 25,000 sq ft building in Cwmbran, Wales that will house brand new R&D space and cGMP analytical labs. The new facility will be 4 times larger than the company's existing location and will allow Nanopharm to increase its capacity to the extent … [Read more...] about Nanopharm announces expansion